These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35431604)

  • 1. Multi-period vaccine allocation model in a pandemic: A case study of COVID-19 in Australia.
    Fadaki M; Abareshi A; Far SM; Lee PT
    Transp Res E Logist Transp Rev; 2022 May; 161():102689. PubMed ID: 35431604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new vaccine supply chain network under COVID-19 conditions considering system dynamic: Artificial intelligence algorithms.
    Kamran MA; Kia R; Goodarzian F; Ghasemi P
    Socioecon Plann Sci; 2023 Feb; 85():101378. PubMed ID: 35966449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty.
    Shiri M; Ahmadizar F
    J Ambient Intell Humaniz Comput; 2022 Jun; ():1-25. PubMed ID: 35692508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decision support system for prioritised COVID-19 two-dosage vaccination allocation and distribution.
    Shahparvari S; Hassanizadeh B; Mohammadi A; Kiani B; Lau KH; Chhetri P; Abbasi B
    Transp Res E Logist Transp Rev; 2022 Mar; 159():102598. PubMed ID: 35185357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.
    Zhu J; Wang Q; Huang M
    Front Public Health; 2023; 11():1129183. PubMed ID: 37168073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An epidemiology-based model for the operational allocation of COVID-19 vaccines: A case study of Thailand.
    Jarumaneeroj P; Dusadeerungsikul PO; Chotivanich T; Nopsopon T; Pongpirul K
    Comput Ind Eng; 2022 May; 167():108031. PubMed ID: 35228772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing an optimization model for the vaccine supply chain during the COVID-19 pandemic.
    Valizadeh J; Boloukifar S; Soltani S; Jabalbarezi Hookerd E; Fouladi F; Andreevna Rushchtc A; Du B; Shen J
    Expert Syst Appl; 2023 Mar; 214():119009. PubMed ID: 36312907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sociotechnical approach to vaccine manufacturer selection as part of a global immunization strategy against epidemics and pandemics.
    Ferreira FAF; Kannan D; Meidutė-Kavaliauskienė I; Vale IMT
    Ann Oper Res; 2022 Jan; ():1-30. PubMed ID: 35068642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the United States COVID-19 vaccine allocation strategy.
    Islam MR; Oraby T; McCombs A; Chowdhury MM; Al-Mamun M; Tyshenko MG; Kadelka C
    PLoS One; 2021; 16(11):e0259700. PubMed ID: 34788345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of health-oriented cross-regional allocation strategies for the COVID-19 vaccine: a mathematical modelling study.
    Yang T; Deng W; Liu Y; Deng J
    Ann Med; 2022 Dec; 54(1):941-952. PubMed ID: 35393922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing Spatio-Temporal Allocation of the COVID-19 Vaccine Under Different Epidemiological Landscapes.
    Cao W; Zhu J; Wang X; Tong X; Tian Y; Dai H; Ma Z
    Front Public Health; 2022; 10():921855. PubMed ID: 35812517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative effectiveness of three and four doses of COVID-19 vaccine in Victoria, Australia: A data linkage study.
    Canevari JT; Cheng AC; Wu L; Rowe SL; Wollersheim DE; West D; Majumdar SS; Sullivan SG
    Vaccine; 2024 Jan; 42(1):53-58. PubMed ID: 38057205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constructing an ethical framework for priority allocation of pandemic vaccines.
    Fielding J; Sullivan SG; Beard F; Macartney K; Williams J; Dawson A; Gilbert GL; Massey P; Crooks K; Moss R; McCaw JM; McVernon J
    Vaccine; 2021 Jan; 39(5):797-804. PubMed ID: 33408013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Allocation of the Limited COVID-19 Vaccine Supply in South Korea.
    Shim E
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33557344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel hybrid multi-criteria group decision-making approach with intuitionistic fuzzy sets to design reverse supply chains for COVID-19 medical waste recycling channels.
    Liu S; Zhang J; Niu B; Liu L; He X
    Comput Ind Eng; 2022 Jul; 169():108228. PubMed ID: 35601730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative performance of between-population vaccine allocation strategies with applications for emerging pandemics.
    Joshi K; Rumpler E; Kennedy-Shaffer L; Bosan R; Lipsitch M
    Vaccine; 2023 Mar; 41(11):1864-1874. PubMed ID: 36697312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-objective two-stage emergent blood transshipment-allocation in COVID-19 epidemic.
    Zhou Y; Cheng J; Wu C; Teo KL
    Complex Intell Systems; 2023 Feb; ():1-19. PubMed ID: 36855682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How can age-based vaccine allocation strategies be optimized? A multi-objective optimization framework.
    Wu H; Wang K; Xu L
    Front Public Health; 2022; 10():934891. PubMed ID: 36159290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.